1. Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity
   Guoyu Pan, 2019, Drug Transporters in Drug Disposition, Effects and Toxicity CrossRef
2. miR-9-5p and miR-221-3p Promote Human Mesenchymal Stem Cells to Alleviate Carbon Tetrachloride-Induced Liver Injury by Enhancing Human Mesenchymal Stem Cell Engraftment and Inhibiting Hepatic Stellate Cell Activation
   Lihong He et al, 2024, International Journal of Molecular Sciences CrossRef
3. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a
   Yong-Zhen Wang et al, 2019, The Journal of Biochemistry CrossRef
4. Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation
   Oliver Bruhn et al, 2020, Molecular Pharmacology CrossRef
5. let-7a suppresses liver fibrosis via TGFβ/SMAD signaling transduction pathway
   Yinghui Zhang et al, 2019, Experimental and Therapeutic Medicine CrossRef
6. Circular RNAs in organ injury: recent development
   Ryan Wong et al, 2022, Journal of Translational Medicine CrossRef
7. Effect of miR‐182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway
   Yu Huang et al, 2018, Journal of Cellular Physiology CrossRef
8. Noncoding RNAs Interactions in Hepatic Stellate Cells during Hepatic Fibrosis
   Siti Aishah Sulaiman et al, 2021, Livers CrossRef
9. Microarray profiling of circular RNAs and the potential regulatory role of hsa_circ_0071410 in the activated human hepatic stellate cell induced by irradiation
   Yuhan Chen et al, 2017, Gene CrossRef
10. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis
    Brenda de Oliveira da Silva et al, 2017, Cell Biology International CrossRef
11. Investigating miR-9 as a mediator in laryngeal cancer health disparities
    Christina Gobin et al, 2023, Frontiers in Oncology CrossRef
12. MicroRNAs in organ fibrosis: From molecular mechanisms to potential therapeutic targets
    Hui Zhao et al, 2021, Pathology - Research and Practice CrossRef
13. Regulation of drug transporters by microRNA and implications in disease treatment
    Yoon-Jee Chae et al, 2022, Journal of Pharmaceutical Investigation CrossRef
14. miR-125b acts as anti-fibrotic therapeutic target through regulating Gli3 in vivo and in vitro
    Zongqiang Hu et al, 2019, Annals of Hepatology CrossRef
15. Inhibition of autophagy reverses alcohol-induced hepatic stellate cells activation through activation of Nrf2-Keap1-ARE signaling pathway
    Zheng-Yuan Xie et al, 2018, Biochimie CrossRef
16. Research on mechanism of tanshinone a in regulating biological characteristics of hematopoietic stem cell in liver cirrhosis through targeting of miR-9a-5p
    Nan Wei et al, 2022, Materials Express CrossRef
17. Inhibition of MicroRNA-9-5p Protects Against Cardiac Remodeling Following Myocardial Infarction in Mice
    Yimin Xiao et al, 2019, Human Gene Therapy CrossRef
18. Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition
    Kimberley M. Hanssen et al, 2021, Drug Resistance Updates CrossRef
19. Downregulation of miR‑152 contributes to the progression of liver fibrosis via targeting Gli3 in�vivo and in�vitro
    Li Li et al, 2019, Experimental and Therapeutic Medicine CrossRef
20. Downregulation of miR‑141 deactivates hepatic stellate�cells by targeting the PTEN/AKT/mTOR pathway
    Haijun Liang et al, 2020, International Journal of Molecular Medicine CrossRef